Article

Rosemary essential oil: neuropharmacological potential in nervous system disorders

Introduction

Rosemary oil, derived from Rosmarinus officinalis (now Salvia rosmarinus), is an essential oil widely studied for its neuropharmacological properties. It contains bioactive constituents such as 1,8-cineole, camphor, α-pinene, and rosmarinic acid, which exhibit antioxidant, anti-inflammatory, cholinergic, and neuroprotective actions. Due to these properties, rosemary oil has gained attention as a potential complementary agent in various nervous system disorders.

Phytochemical profile relevant to neuroactivity

Major bioactive constituents:

1,8-cineole: enhances cholinergic transmission
Camphor: modulates central nervous system excitability
α-pinene: exhibits anti-inflammatory and anxiolytic potential
Rosmarinic acid: strong antioxidant and neuroprotective agent

Mechanistic relevance:

These phytochemicals interact with neurotransmitter systems, oxidative stress pathways, and neuroinflammatory cascades, contributing to their therapeutic potential in neurological conditions.

Neuropharmacological mechanisms of action

Cholinesterase inhibition:

Rosemary oil has been shown to inhibit acetylcholinesterase activity, leading to increased acetylcholine availability in synaptic clefts. This mechanism supports cognitive enhancement and memory improvement.

Antioxidant and neuroprotective effects:

The oil scavenges reactive oxygen species and reduces lipid peroxidation, protecting neuronal membranes from oxidative damage. This is particularly relevant in neurodegenerative disorders.

Anti-inflammatory modulation:

It downregulates pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, reducing neuroinflammation associated with chronic neurological diseases.

Modulation of neurotransmission:

Rosemary oil influences GABAergic, dopaminergic, and serotonergic pathways, contributing to anxiolytic, antidepressant, and neuro-stabilizing effects.

Role in specific nervous system disorders

Cognitive impairment and dementia:

Improves memory retention and attention¹
May slow cognitive decline via antioxidant and cholinergic mechanisms
Potential supportive role in Alzheimer’s disease

Anxiety disorders:

Exerts mild anxiolytic effects through GABA modulation
Reduces stress-induced autonomic hyperactivity
Improves relaxation and sleep quality²

Depression:

Modulates monoaminergic neurotransmitters
Reduces oxidative stress linked to depressive pathology
May improve mood and emotional stability

Neurodegenerative diseases:

Protective effects against neuronal apoptosis
Reduces amyloid-beta induced toxicity (experimental evidence)
Supports mitochondrial function and neuronal survival

Headache and migraine:

Analgesic and vasomodulatory effects
May reduce frequency and intensity of tension-type headaches

Clinical and experimental evidence

Preclinical studies demonstrate improved memory performance, reduced oxidative stress markers, and enhanced cholinergic activity following rosemary oil exposure. Limited clinical trials suggest benefits in cognitive performance, alertness, and mood modulation, although large-scale randomized controlled trials remain insufficient.

Routes of administration and therapeutic application

Aromatherapy:

Inhalation enhances alertness and cognitive performance
Commonly used in stress-related disorders

Topical application:

Diluted essential oil used in massage therapy³
May improve circulation and reduce tension-related pain

Oral supplementation (controlled settings):

Used in low doses in some experimental formulations
Requires caution due to potential toxicity at high concentrations

Safety profile and toxicological considerations

Rosemary oil is generally safe in low therapeutic doses; however:

High doses may cause neurotoxicity or seizures due to camphor content
Contraindicated in epilepsy and pregnancy without medical supervision
Skin irritation may occur if used undiluted

Conclusion

Rosemary oil exhibits significant neuropharmacological potential due to its cholinesterase inhibitory, antioxidant, anti-inflammatory, and neurotransmitter-modulating properties. Evidence supports its possible role as an adjunct therapy in cognitive impairment, anxiety, depression, and neurodegenerative disorders. However, clinical validation through large-scale human studies is essential to establish standardized dosing, safety profiles, and therapeutic efficacy.

References:

1. Ghasemzadeh Rahbardar M, Hosseinzadeh H. Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders. Iran J Basic Med Sci. 2020;23(9):1100-1112. doi:10.22038/ijbms.2020.45269.10541. https://pmc.ncbi.nlm.nih.gov/articles/PMC7491497/
2. Priya V, Srinivasan D, Priyadarsini S, et al. Anxiolytic, Antidepressant and Healthy Sleep-Promoting Potential of Rosmarinic Acid: Mechanisms and Molecular Targets. Neuropsychiatr Dis Treat. 2025;21:641-661. Published 2025 Mar 20. doi:10.2147/NDT.S501597. https://pmc.ncbi.nlm.nih.gov/articles/PMC11934053/
3. Sayorwan W, Ruangrungsi N, Piriyapunyporn T, Hongratanaworakit T, Kotchabhakdi N, Siripornpanich V. Effects of inhaled rosemary oil on subjective feelings and activities of the nervous system. Sci Pharm. 2013;81(2):531-542. doi:10.3797/scipharm.1209-05. https://pmc.ncbi.nlm.nih.gov/articles/PMC3700080/